ICGC Goal: To obtain a comprehensive description of genomic, transcriptomic and epigenomic changes in 50 different tumor types and/or subtypes which are of clinical and societal importance across the globe.
Read more »
- 27/March/2013 - The ICGC Data Coordination Center (DCC) is pleased to announce the ICGC data portal data release 12 (http://dcc.icgc.org).
ICGC data release 12 in total comprises data from 7,774 cancer genomes.
- Currently, the ICGC has received commitments from funding organizations in Asia, Australia, Europe, North America and South America for 53 project teams in 15 jurisdictions to study over 25,000 tumor genomes. Projects that are currently funded are examining tumors affecting the bladder, blood, bone, brain, breast, cervix, colon, head and neck, kidney, liver, lung, oral cavity, ovary, pancreas, prostate, rectum, skin, soft tissues, stomach, thyroid and uterus. Over time, additional nations and organizations are anticipated to join the ICGC. The genomic analyses of tumors conducted by ICGC members in Australia (pancreatic cancer), Canada (pancreatic cancer, pediatric brain cancer and prostate cancer), China (gastric cancer), France (liver cancer), Germany (blood cancer, brain cancer), Japan (liver cancer), Spain (blood cancer), the UK (blood, breast, lung, prostate and skin cancer) and the USA (blood, bladder, brain, breast, cervical, colon, head and neck, kidney, liver, lung, ovarian, prostate, rectal, skin, stomach, thyroid and uterine cancer) are now available through the Data Coordination Center housed on the ICGC website at www.icgc.org.
- International network of cancer genome projects. Nature 464, 993-998 (15 April 2010)
Read the article
The International Cancer Genome Consortium (ICGC) has been organized to launch and coordinate a large number of research projects that have the common aim of elucidating comprehensively the genomic changes present in many forms of cancers that contribute to the burden of disease in people throughout the world.
The primary goals of the ICGC are to generate comprehensive catalogues of genomic abnormalities (somatic mutations, abnormal expression of genes, epigenetic modifications) in tumors from 50 different cancer types and/or subtypes which are of clinical and societal importance across the globe and make the data available to the entire research community as rapidly as possible, and with minimal restrictions, to accelerate research into the causes and control of cancer. The ICGC facilitates communication among the members and provides a forum for coordination with the objective of maximizing efficiency among the scientists working to understand, treat, and prevent these diseases.